MCT2D | Michigan Collaborative for Type 2 Diabetes
@MCT2D
The Michigan Collaborative for Type 2 Diabetes seeks to engage and empower clinicians & patients across the state to improve #Type2 care. A @MichiganCQIs
If we were a sandwich...WAIT, we *ARE* a sandwich. Introducing our collab with @eatbreadless: the BLT2D. Available to order (or get delivered) TODAY! https://t.co/AwgdyJyp4Z
Advocating for yourself at the doctor's office can be overwhelming. 😓
Use these cards at your next doctor appointment to make sure you’re getting the care that you deserve!
https://t.co/1jVhSsOfUJ
The @AmDiabetesAssn is seeking diverse leaders with vision & expertise! The National Board of Directors is accepting applications for its 2025 Class. Board members play a vital role in shaping our organization's future. Apply by July 31, 2024, 8:00 pm ET. https://t.co/9EOOiRgABZ
This JAMA Internal Medicine Patient Page describes how to use injectable weight-loss medications as well as their risks and benefits. https://t.co/wVyxw0lQly
The Health Disparities Committee’s Top 10 Recommended Abstracts recognizes abstracts that have been accepted to the 84th #ADASciSessions. These abstracts focus on health care disparities/inequities in diabetes outcomes. For more information, visit https://t.co/bcCnMJKh0g.
@DiabetesDiezy@wwmtnews The TV segment included a link to the @mct2d resource library, with tools to navigate medication affordability, cost, and coverage, as well as a guide to switching medications during a GLP-1 RA shortage https://t.co/p7YL3wsHk8
GLP-1 RA shortages have disrupted diabetes care. Co-director @DiabetesDiezy spoke to @wwmtnews on the impact felt in Michigan and resources from @MCT2D https://t.co/8YFqqmAsGh
Love the paradigm shift @l_oshman and @MCT2D are leading to “new school” thinking that T2 diabetes is preventable and addressing #obesity in primary care is a key tactic along with patient and community engagement #ADASciSessions#theTeam 💙💛
What are the keys to activating statewide change in T2D care? Learn from a pro—@MCT2D director @l_oshman Monday 1:30 #ADASciSessions https://t.co/ouScsm2oME
GLP-1 RA and SGLT2i prescribing in primary care for type 2 diabetes is on the rise, according to findings from our statewide @MichiganCQIs. Chat with us #ADASciSessions Sun 12:30-1:30 in the poster hall (1073-P) https://t.co/rFqa0XQnm4
Way to go @l_oshman and @MCT2D for championing patients - these medications can be lifesavers for patients who are most severely affected by obesity and its complications! @umfamilymed
The top of the front page of today’s @freep has a story on #obesity medication costs & coverage, quoting our member @l_oshman of @umfamilymed@MCT2D and citing data from our National Poll on Healthy Aging:
Story in today's @freep featuring Fam Med Dr. @l_oshman, program director of @MCT2D, about the high cost of weight loss drugs and their threats to health insurance. Read the story here: https://t.co/EIoQiWQ3xA
Which type of carb can help minimize post-meal high blood sugar? Rina, our dietitian lead, explains: “We can consider it one of our best friends." Her tips, shared with @diaTribeNews https://t.co/RQ8Ab2FL3T
Dr. @l_oshman of @MCT2D is featured in a front-page story of @freep today, discussing the financial impact of weight-loss drugs: https://t.co/ir8UgsbWi2
Program Manager for @MichBariSC and @MSQCPSO, @ALStricklen is featured in a new article on @MLIVE! Learn about her ongoing work as a Presidential Scholar: https://t.co/lMnqiELWdw
Great crowds for the @NAPCRG presentation by @l_oshman, Larrea Young & team, who conducted a study about grocery delivery & low carb education to support patients with type 2 diabetes & food insecurity. @HBOMich@MCT2D. Thanks to all who attended! Details: https://t.co/d2tTUeZOoE
Next in our diabetes sessions @b4lynn27 in the critical period of primary care continuity of care in the 3 yesr period following a #prediabetes dx in a rural pop https://t.co/lJgFK9mMYN #napcrg2023